Study of Safe Blood Transfusion Volumes to Correct Acute Severe Anaemia
NCT01461590 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2015-04-01
Summary
Greater volume of whole blood(30mls/kg compared to 20mls/kg) following standard calculations, given to children with severe anaemia will be beneficial in haematological correction and can be given safely since respiratory distress and haemodynamic changes result from acidosis and compensation in these children rather than from biventricular failure.
Conditions
- Severe Anaemia
Interventions
- OTHER
-
Whole blood
30mls/kg transfused over fours hours
- OTHER
-
Whole blood
20mls/kg transfused over four hours
Sponsors & Collaborators
-
Imperial College London
collaborator OTHER -
Prof Kathryn Maitland
lead OTHER
Principal Investigators
-
Charles Engoru, MMed, MBChB · Soroti Regional Hospital, Uganda
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Days
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2012-01-31
- Completion
- 2012-01-31
Countries
- Uganda
Study Locations
More Related Trials
-
A Study to Observe the Causes and Treatment of Anemia in Critically Ill Children
NCT00211055 ·Status: COMPLETED
-
PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions
NCT02087553 ·Status: COMPLETED
-
Effect Evaluation of Different Blood Products Infusion on Neonatal Anemia
NCT06285604 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia
NCT06302491 ·Status: RECRUITING ·Phase: PHASE2
-
Assesment of Treatment Outcomes of Aquired Aplastic Anemia in Children : A Retrospective and Prospective Cohort
NCT07131878 ·Status: NOT_YET_RECRUITING
-
the Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis
NCT03748043 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044
NCT04269707 ·Status: COMPLETED ·Phase: PHASE3
-
Moderate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa
NCT02675790 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia
NCT04968379 ·Status: WITHDRAWN ·Phase: PHASE2
-
Reduced Intensity Transplant Conditioning Regimen for Severe Thalassemia
NCT01005576 ·Status: COMPLETED ·Phase: PHASE2
-
Stroke With Transfusions Changing to Hydroxyurea
NCT00122980 ·Status: TERMINATED ·Phase: PHASE3
-
Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial
NCT00072761 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge
NCT04920045 ·Status: TERMINATED ·Phase: NA
-
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
NCT00395993 ·Status: COMPLETED ·Phase: PHASE3
-
MAST - Magnesium for Sickle Cell Acute Crisis in Children
NCT00313963 ·Status: COMPLETED ·Phase: PHASE3
-
Novel Use Of Hydroxyurea in an African Region With Malaria
NCT01976416 ·Status: COMPLETED ·Phase: PHASE3
-
Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia
NCT04301336 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD)
NCT01783691 ·Status: COMPLETED ·Phase: PHASE1
-
Stroke Prevention in Sickle Cell Anemia (STOP 1)
NCT00000592 ·Status: COMPLETED ·Phase: PHASE3
-
Iron Status in BTM With Blood Transfusion
NCT04947540 ·Status: UNKNOWN
-
IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
NCT02541708 ·Status: UNKNOWN ·Phase: PHASE3
-
Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease
NCT00459225 ·Status: WITHDRAWN ·Phase: NA
-
Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)
NCT01531387 ·Status: TERMINATED ·Phase: PHASE3
-
Daily Versus Alternate Day Regimen of Iron Supplementation in Children with Iron Deficiency Anemia
NCT06631612 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Effect of Incentive Respiratory Training on Pulmonary Functions and Functional Capacity in Children With B-thalassemia Major
NCT07112703 ·Status: RECRUITING ·Phase: NA